e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Recent advances in the treatment and pathogenesis of pulmonary diseases II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Levels of NO in exhaled air at patients with chronic obstructive pulmonary diseases in high altitude
A. Myrzaahmatova, T. Sooronbaev (Byshkek, Kyrgyzstan)
Source:
Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Session:
Recent advances in the treatment and pathogenesis of pulmonary diseases II
Session type:
E-Communication Session
Number:
4635
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Myrzaahmatova, T. Sooronbaev (Byshkek, Kyrgyzstan). Levels of NO in exhaled air at patients with chronic obstructive pulmonary diseases in high altitude. Eur Respir J 2008; 32: Suppl. 52, 4635
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Urban air pollution and chronic obstructive pulmonary disease: a review
Source: Eur Respir J 2001; 17: 1024-1033
Year: 2001
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 439-443
Year: 2003
Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 269-274
Year: 2005
Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight
Source: Eur Respir J 2005; 25: 725-730
Year: 2005
Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005
Pulmonary hypertension frequency in patients with chronic obstructive pulmonary disease exposed to biomass or tobacco smoke
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020
Early detection of patients with asthma or chronic bronchitis by investigation on exhaled air condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 275s
Year: 2002
Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) at the remote period after radiation exposure
Source: Eur Respir J 2007; 30: Suppl. 51, 338s
Year: 2007
Are acute changes in CO2 measurable with transcutaneous technique in patients with very severe chronic obstructive pulmonary disease?
Source: International Congress 2015 – COPD: notable points
Year: 2015
Monocyte subpopulations, airway inflammation and lung function in patients with occupational chronic obstructive pulmonary disease from exposure to industrial aerosols containing nanoparticles
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020
The impact of airborne occupational exposure in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - The impact of airborne occupational exposure in COPD
Year: 2010
A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Measurement of exhaled gases in chronic airway diseases
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017
Prevalence of chronic obstructive pulmonary disease in male workers exposed to dust, gas and fume
Source: Annual Congress 2011 - Work-related respiratory diseases and specific exposures
Year: 2011
Role of inhaled antioxidants in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 717s
Year: 2005
Nasal high flow versus Non-invasive ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2019 – Treatment of acute respiratory failure with noninvasive ventilation
Year: 2019
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004
The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004
Changes of the lipid spectrum of pulmonary surfactant in patients with chronic obstructive bronchitis of miners
Source: Eur Respir J 2002; 20: Suppl. 38, 256s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept